🇺🇸 VCEL — Vericel Corporation

Salud Compra fuerte
← Volver

Precio actual

45,48 USD

Máx. histórico

1.410,00

10633 días

Split 1:20 del 16/10/2013

Caída desde máximo

-96,77%

Rango 52 semanas

28,95 – 49,32

Variación hoy

+10,68%

Cierre anterior

41,09

Rango de hoy

42,07 – 45,98

Volumen hoy

1.742.273

Peor caída histórica

-99,88%

24/09/1997 → 17/11/2015

Aún sin recuperar

Volatilidad anualizada ⓘ

97,58%

Información
Nombre completo
Vericel Corporation
Divisa
USD
Mercado
NasdaqGM
Sector
Salud
Industria
Biotechnology
Empleados
398
PER ⓘ
96,77 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
59,71 USD (puede no estar actualizado)
Primera cotización
04/02/1997
Precio actualizado
hace 9 horas
Sobre la empresa

Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies and specialty biologic products for sports medicine and severe burn care markets in North America. The company markets autologous cell therapy products comprising MACI, an autologous cultured chondrocytes on porcine collagen membrane for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; Epicel, a permanent skin replacement humanitarian use device for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns; and NexoBrid, a biological orphan product for eschar removal in adults and pediatric patients with deep partial-thickness and/or full-thickness thermal burns. Vericel Corporation was formerly known as Aastrom Biosciences, Inc. and changed its name to Vericel Corporation in November 2014. The company was incorporated in 1989 and is headquartered in Burlington, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
16/10/2013 1:20
18/02/2010 1:8
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
12/03/2009 67,20 68,80 62,40 64,00 -2,44% 9,52% 8.231
11/03/2009 70,40 70,40 64,00 65,60 +2,50% 9,09% 9.669
10/03/2009 72,00 75,20 60,80 64,00 -9,09% 20,00% 18.338
09/03/2009 99,20 99,20 65,60 70,40 +33,33% 33,87% 61.124
06/03/2009 62,40 62,40 51,20 52,80 -2,94% 17,95% 11.041
05/03/2009 62,40 62,40 54,40 54,40 -12,82% 12,82% 4.219
04/03/2009 75,20 75,20 60,80 62,40 -7,14% 19,15% 9.650
03/03/2009 49,60 88,00 49,60 67,20 +27,27% 77,42% 17.751
02/03/2009 60,80 60,80 51,20 52,80 -10,81% 15,79% 8.063
27/02/2009 62,40 62,40 57,60 59,20 -9,76% 7,69% 6.821
26/02/2009 65,60 67,20 62,40 65,60 +0,00% 7,32% 4.863
25/02/2009 68,80 75,20 64,00 65,60 -6,82% 16,28% 6.256
24/02/2009 65,60 72,00 65,60 70,40 +7,32% 9,76% 6.824
23/02/2009 72,00 75,20 64,00 65,60 -8,89% 15,56% 10.781
20/02/2009 72,00 76,80 64,00 72,00 -4,26% 17,78% 13.018
19/02/2009 83,20 88,00 73,60 75,20 -9,62% 17,31% 10.057
18/02/2009 96,00 96,00 80,00 83,20 -8,77% 16,67% 12.288
17/02/2009 84,80 96,00 81,60 91,20 +9,62% 16,98% 15.062
13/02/2009 81,60 84,80 78,40 83,20 +0,00% 7,84% 8.373
12/02/2009 83,20 91,20 81,60 83,20 +0,00% 11,54% 8.494
11/02/2009 91,20 91,20 80,00 83,20 -5,45% 12,28% 9.723
10/02/2009 99,20 100,80 86,40 88,00 -9,84% 14,52% 14.702
09/02/2009 108,80 110,40 96,00 97,60 -4,69% 13,24% 11.438
06/02/2009 108,80 112,00 100,80 102,40 -1,54% 10,29% 15.739
05/02/2009 102,40 110,40 97,60 104,00 +1,56% 12,50% 13.389
04/02/2009 104,00 105,60 97,60 102,40 +3,23% 7,69% 9.378
03/02/2009 102,40 104,00 96,00 99,20 -1,59% 7,81% 9.610
02/02/2009 104,00 108,80 94,40 100,80 -13,70% 13,85% 25.452
30/01/2009 112,00 124,80 108,80 116,80 +10,61% 14,29% 50.953
29/01/2009 92,80 105,60 86,40 105,60 +17,86% 20,69% 16.705